A Phase 1 Safety and Dose-Finding Study of a Human Insul

Project: Research project

Project Details

Description

A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Iduronate 2-Sulfatase (IDS) Fusion Protein, AGT-182 in Adult Patients with Mucopolysaccharidosis II (MPS II, Hunter Syndrome)
StatusFinished
Effective start/end date10/5/154/30/18

Funding

  • ARMAGEN, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.